The Association for the British Pharmaceutical Industry (ABPI has appointed UCB’s Steve Arnold to its board of management.
Arnold joined UCB in May this year as managing director of the British and Irish Isles folliwng a spell in Canada working for Gilead Sciences.
He will serve as board member of the ABPPI – the UK’s trade body for the pharma industry – up to 2014.
“As a leading UK pharma investor, UCB believes that harnessing this scientific innovation and increasing our R&D focus is key to improving the UK’s future prosperity and as a member of the ABPI’s board of management I will be working to ensure that life sciences remain vibrant in the UK,” said Arnold.
“This is particularly important at such a challenging time for our industry when we are looking for the Government to provide the right fiscal, R&D and commercial environment for our industry to thrive.”